Medical Waste Containers Market Report Scope & Overview:
Get more information on Medical Waste Containers Market - Request Sample Report
Medical Waste Containers Market Size was valued at USD 2.0 Billion in 2023 and is expected to reach USD 3.91 Billion by 2032, growing at a CAGR of 7.7% over the forecast period 2024-2032.
The Medical Waste Containers Market report provides key statistical insights and trends that are shaping the industry. It reflects the worldwide occurrence and frequency of medical waste, highlighting regional variations in waste generation. The report is a detailed analysis of regulatory compliance and standards adoption and checks compliance with OSHA, EPA, and WHO guidelines. Additionally, it analyzes market volume and growth projections, emphasizing the rising demand for reusable and disposable containers. It also studies trends in materials composition at least some of which are eco-friendly and/or biodegradable. In addition to healthcare spending focusing on waste disposal management, the study delves into technological advancements, including the use of tracking and automated smart waste containers. This report provides a comprehensive data-based overview of the industry. Regulations for Compliance Drive the Demand for Medical Waste Disposal Solutions. In 2023, the U.S. EPA reported a 20% rise in medical waste generation since 2021, aligning with expanded healthcare infrastructure post-pandemic.
Market Dynamics
Drivers
-
Expansion of healthcare facilities in emerging economies increases medical waste generation, necessitating efficient containment solutions.
A key factor contributing to growth of the medical waste containers market is the increase in healthcare facilities, especially in the developing economies. This growth causes medical waste generation, requiring efficient containment solutions. Top private hospital chains are developing over 30,000 beds in India at an investment of about ₹32,500 crore over the next four to five years. Fortis Healthcare aims to add 700 beds in FY25, while Apollo Hospitals Enterprise aims to add 1,170 beds during this period. Advocate Health, the largest non-profit hospital system in the U.S., recently announced a $1 billion investment to construct a new facility in Chicago’s South Side. The project would replace an old 263-bed hospital with a 52-bed facility running on modern principles of primary care and outpatient services. These expansions are prompted by increased demand for healthcare services, better access to medical care, and initiatives to promote health equity. With the expansion of healthcare infrastructures, medical waste generation has also increased, making appropriate waste management solutions imperative. As a result, the need for specialized medical waste containers is anticipated to increase, ensuring safe and compliant disposal of medical waste in these burgeoning healthcare settings.
Restraints:
-
High costs of advanced, eco-friendly medical waste containers deter adoption, especially in budget-constrained healthcare settings.
High costs of advanced eco-friendly medical waste containers are a significant restraint for their wide adoption and end users in healthcare settings with limited budget. Often made with sustainable materials, these containers can include advanced smart technologies, including built-in sensors and RFID tracking, to enhance safety and environmental sustainability. However, the manufacturing and integration of these advanced features increase production costs, leading to higher market prices. This financial constraint is most evident in small healthcare facilities and in value-sensitive regions, where healthcare budgets for waste management barely exist. As a result, these facilities may choose cheaper, traditional waste disposal methods that may not comply with any current safety and environmental regulations. As a consequence, this is a cost part challenge that emphasizes the provision of reasonable solutions that balance security, compliance, and environmental factors for practical adoption and practice of correct medical waste disposal.
Opportunities:
-
Integration of IoT technology in waste management offers smart solutions, enhancing efficiency and compliance in medical waste disposal.
The inclusion of IoT technology in medical waste management creates a great opportunity to streamline the efficiency of care and compliance in disposal practices. IoT devices like sensors fixed on waste bins can monitor the waste levels in real-time, allowing the timely collection and preventing overflow. Optimized collection routes made possible by this technology translate into significant fuel savings and minimized emissions. For example, OSF HealthCare Saint Anthony's Health Center in Alton, Ill., had a used medical sensor capture rate of 72.6%, far above the national average, through careful collection and remanufacturing efforts.
This growth is driven by the increasing volume of medical waste, which, if not properly managed, poses significant infection risks. Therefore, it is necessary to follow proper measures for the collection, segregation, transportation, treatment, and disposal of waste produced from hospitals to avoid contamination and increase environmental sustainability, which can be achieved by IoT medical waste management solutions. However, applying IoT in healthcare waste management does not come without difficulties. Infrastructure limitations, especially in developing regions, can hinder the adoption of IoT devices. Furthermore, potential data security risks and the initial investment needed for IoT integration on-site can also pull back implementations at some healthcare units. However, the potential for IoT to improve medical waste management efficiency and regulatory compliance positions it well for future development.
Challenges:
-
Limited awareness and infrastructure for proper medical waste management in developing regions hinder effective implementation of waste disposal practices.
A lack of knowledge and infrastructure is challenging medical waste management in the developing world. According to a 2024 report by the United Nations Environment Programme (UNEP), global municipal solid waste generation is expected to nearly double, from 2.1 billion tonnes in 2023 to 3.8 billion tonnes by 2050, pointing to an urgent need for improved waste management systems. Moreover, data from 54 low- and middle-income countries show that 38% of health facilities do not have improved water sources, 19% do not have improved sanitation and 35% do not have access to water and soap for handwashing. The unavailability of the most basic Water, Sanitation, and Hygiene (WASH) amenities undermines both routine services and the prevention and control of infections. Inadequate infrastructure as well as lack of awareness, results in dumping waste in the open or burning it without emission control which puts a greater risk to public health and the environment. Such efforts could include investing in waste management infrastructure, targeting healthcare workers for training on safe disposal practices, and implementing stringent regulatory frameworks to ensure compliance and protect community health.
Segment analysis
By Product
In 2023, the chemotherapy waste container segment captured the largest product share 37.0%, due to increasing incidences of cancer and stringent disposal guidelines for cytotoxic medications. As the U.S. National Cancer Institute (NCI) data revealed, cancer incidence ballooned to 2.1 million new cases in 2025, which was a 12% growth as compared to 2020, and thus required safer handling for chemotherapy waste. The EPA’s 2024 Hazardous Waste Pharmaceuticals Rule labeled those cytotoxic remains as “acute hazardous waste” that must be disposed of in puncture-resistant, tamper-proof containers with walls 2.5mm thick. Internationally, the EU’s 2023 Medical Device Regulation (MDR) mandated use of color-coded containers (purples for cytotoxic waste) to limit cross-contamination. The Federal Ministry for the Environment in Germany finally allocated funding in 2025 for the supply of automated chemotherapy waste systems meeting the DIN 13063 standard to oncology units to be covered with €30 million. Similarly, Japan’s Ministry of Health reported 450,000 cancer patients in 2024, spurring a 25% annual demand for high-density polyethylene (HDPE) containers. Emerging markets such as Brazil also embraced ANVISA Resolution RDC 222/2024, which mandated double-layered chemotherapy containers that were labeled with a biohazard symbol. These regulations, along with pharma behemoths like Roche and Novartis joining forces with waste companies for take-back programs, secured the supremacy of the segment.
By Waste Type
The general medical waste revenue share, accounted for 36% of revenue share, due to the large amounts of non-infectious disposables such as gloves and packaging being generated. According to the U.S. EPA’s 2024 data, 88% of medical waste is general, and 50% is generated in outpatient facilities (33 billion visits per year according to CDC 2023). In 2023, the 2003 EU Landfill Directive (2003/33/EC) prohibited the disposal of untreated general medical waste, requiring the segregation of waste into special blue containers. In 2024, the UK Environment Agency fined 1,200 clinics with fines for improper container labeling, prompting the rapid uptake of UN 3291-certified bins. Australia’s National Health and Medical Research Council (NHMRC) reported that 70 percent of rural clinic waste consists of general item waste, creating demand for inexpensive HDPE containers. However, challenges persist in low-income regions: WHO’s 2024 assessment found only 30% of African clinics segregate general waste, leading to mixed waste dumping. Governments are responding with measures such as Kenya’s 2025 Medical Waste Policy, which subsidizes 50,000 containers for primary healthcare centers.
By End Use
Hospitals and private clinics are the largest end-users with 37% revenue share, due to high patient throughput and complex waste streams. In 2025, there were reportedly 35.2 million hospital admissions in the U.S. AHA, producing 5.9 million tonnes of waste, with 60% needing a specialized container. India’s 2024 Bio-Medical Waste Management Rules levied ₹500,000 fines on 1,200 clinics for using non-compliant containers, fuelling demand for 1.2 million units every year. In Europe, France’s 2025 Circular Economy Law required RFID-tagged containers for traceability, with 80% of Parisian hospitals adopting them by Q1 2025. Japan’s Ministry of Health, Labour and Welfare enacted a regulation last year that required clinics to store infectious waste in anti-microbial containers made of polypropylene by 2024, increasing sales by 18%, according to the company. Meanwhile, U.S. private clinics, which contribute 45% of outpatient waste (HHS 2025), prioritized space-efficient solutions like foldable containers. However, cost barriers hampered smaller facilities: Kenya’s 2025 Health Ministry survey found that 65% of clinics reused containers due to budget constraints, prompting subsidies for 30-liter bins.
Regional Analysis
North America was the dominant region in 2023, accounting for 42% of the market share, driven by strict regulations such as the EPA and Health Canada regulations that arose due to the enforcement of the EPA’s Resource Conservation and Recovery Act (RCRA) and state-level mandates. U.S. generated 6.2 million tonnes of medical waste in 2024 (EPA) & California’s SB 1383 mandates reusable containers at 75% of healthcare facilities by 2025. Health Canada’s 2025 Single-Use Plastics Ban accelerated the adoption of stainless-steel containers, which captured 28% of the regional market as hospitals like Toronto General invested $15 million in sterilization-compliant systems. The 2024 NOM-087-SEMARNAT-SSA1 regulation in Mexico required more rigid containers for infectious waste, contributing to a 30% rise in imports of U.S.-made containers (INEGI, 2025). The HHS until recently reported that clinics serving rural U.S. patients are spending 40% more managing its garbage versus those in urban areas, because of inefficiencies in transporting waste to landfills.
Asia Pacific region is anticipated to gain with higher CAGR through the forecast period, APAC's rapid growth is attributed to investment in healthcare infrastructure in countries including India and China. India’s Ayushman Bharat system expanded to 200,000 well healthcare centers by 2025, producing 800 tonnes/day of hospital waste (CPCB). The FSSAI's autoclave-compatible stainless containers mandate for 2024 has spurred a 25% YoY sales surge for domestic manufacturers such as Bharat Containers. In China, for instance, the $2.2 billion hospital upgrade initiative (NDRC, 2025) enabled smart containers with IoT sensors to be prioritized, with Shanghai once deploying 500,000 units of these. In 2024, PMDA (Japan’s Pharmaceutical and Medical Devices Agency) approved 22 new container models targeting cytotoxic waste from 480,000 cancer patients (MHLW).
Need any customization research on Medical Waste Containers Market - Enquiry Now
Key Players
Key Service Providers/Manufacturers
-
Stericycle (Sharps Disposal Containers, Medical Waste Boxes)
-
Daniels Health (Sharpsmart Containers, Medismart Containers)
-
Bemis Manufacturing Company (Sharps Containers, Chemotherapy Waste Containers)
-
Covidien (Medtronic) (Kendall Sharps Disposal Containers, Chemosafety Containers)
-
BD (Becton, Dickinson and Company) (BD Sharps Collectors, BD Recykleen Containers)
-
Thermo Fisher Scientific (Nalgene Biohazardous Waste Containers, Sterilin Waste Containers)
-
Cardinal Health (Sharps-A-Gator Containers, Chemotherapy Waste Containers)
-
Henry Schein (Sharps Disposal Containers, Biohazard Waste Bags)
-
VWR International (Sharps Containers, Biohazard Incinerator Boxes)
-
Mauser Packaging Solutions (Medical Waste Drums, Biohazard Containers)
-
Justrite (Biohazard Waste Cans, Medical Waste Containers)
-
Onyx Medical (Sharps Containers, Medical Waste Bins)
-
EnviroTain (Medical Waste Containers, Biohazard Waste Containers)
-
Sharps Compliance, Inc. (Sharps Recovery System, TakeAway Recovery System)
-
GPC Medical Ltd. (Biohazard Waste Containers, Sharps Containers)
-
Medegen Medical Products (Sharps Containers, Chemotherapy Waste Containers)
-
Plastican Inc. (Medical Waste Containers, Biohazard Pails)
-
Eagle Manufacturing Company (Biohazard Waste Containers, Medical Waste Incinerator Cans)
-
Narang Medical Limited (Sharps Containers, Biohazard Waste Bins)
-
ThermoSafe (Medical Waste Containers, Biohazard Transport Containers)
Recent Developments
-
In August 2023, the Kozhikode Corporation, under a new project, initiated the collection of biomedical waste through the mobile application AAKRI and awarded the contract to A4 Mercantiles Private Ltd.
-
In 2023, TBS Energi Utama expanded its business portfolio beyond the coal mining sector by acquiring Asia Medical Enviro Services, a prominent company specializing in biohazardous and medical waste treatment.
Report Attributes | Details |
---|---|
Market Size in 2023 | USD 2.0 Billion |
Market Size by 2032 | USD 3.91 Billion |
CAGR | CAGR of 7.7% From 2024 to 2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Product (Chemotherapy Containers, Biohazardous Medical Waste Containers, Resource Conservation and Recovery Act (RCRA) Containers, Others) • By Waste type, (General Medical Waste, Infectious Medical Waste, Hazardous Medical Waste, Others) • By End-use (Hospitals & Private Clinics, Diagnostic Laboratories, Research Institutes, Others) |
Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
Company Profiles | Stericycle, Daniels Health, Bemis Manufacturing Company, Covidien (Medtronic), BD (Becton, Dickinson and Company), Thermo Fisher Scientific, Cardinal Health, Henry Schein, VWR International, Mauser Packaging Solutions, Justrite, Onyx Medical, EnviroTain, Sharps Compliance, Inc., GPC Medical Ltd., Medegen Medical Products, Plastican Inc., Eagle Manufacturing Company, Narang Medical Limited, ThermoSafe |